Logo

American Heart Association

  167
  0


Final ID: WP52

Cognitive impairment in patients with intracranial atherosclerosis at different stages: an observational study

Abstract Body: Background Emerging evidence suggests intracranial atherosclerosis (ICAS) is associated with an increased risk of dementia. However, few data have focused on the cognitive impairment in patients with ICAS at different stages.
Methods Consecutive patients with ICAS at different stages (asymptomatic ICAS <50%, asymptomatic ICAS ≥50%, symptomatic ICAS ≥50%) and age-sex matched normal controls, diagnosed by magnetic resonance angiography and vessel wall imaging, were recruited. Cognitive status was assessed with a neuropsychological battery and daily life ability evaluations. Plasma biomarkers were measured, including Aβ42, Aβ40, p-tau217, GFAP and NfL. Conventional MRI, diffusion tensor imaging, and resting-state functional MRI were conducted. Compared to the normal control group, we developed personalized and interpretable scores for brain circuit dysfunction, applying a theoretical taxonomy to describe the abnormal structural and functional neural networks linked to cognitive domains in ICAS patients.
Results We enrolled 455 patients with ICAS (age 56.0 ± 13.0 years, 60% male) and 158 controls (age 58.30 ± 11.14 years, 50% male). The prevalence of dementia and mild cognitive impairment was 0.6% and 22.1% in the control group, 1.0% and 29.1% in patients with asymptomatic ICAS <50% (n=103), 2.4% and 30.2% in those with asymptomatic ICAS ≥50% (n=212), and 10.6% and 42.1% in individuals with symptomatic ICAS ≥50% (n=140), respectively. Compared to controls, only patients with symptomatic ICAS showed a significant decrease in the Aβ42/Aβ40 ratio (p<0.05) and an increase in NFL level (p<0.05). In contrast, the P-tau 217 and GFAP levels were similar across ICAS groups and control groups. The burden of cerebral small vascular disease (CSVD) increased progressively across ICAS stages, with the frequency of a CSVD score ≥ 4 being 9.8%, 9.6%, and 33.4%, respectively, compared to 5.4% in the control group. However, this did not affect the independent impact of ICAS on cognition (β =0.54, P=0.035). Disruptions in both structural and functional connectivity were evident in brain networks, with an increasingly pronounced decline observed by brain circus score, especially in the memory network (-1.22, -5.88, -6.74, vs. control) across ICAS stages .
Conclusion Cognitive impairment can occur at the early stage of patients with ICAS and varies in severity and mechanisms across stages. Treatment and prevention strategies should be specifically tailored.
  • Liu, Caiyan  ( Peking Union Medical College Hospital , Beijing , China )
  • Cheng, An-qi  ( Peking Union Medical College Hospital , Beijing , China )
  • Zou, Yinxi  ( Peking Union Medical College Hospital , Beijing , China )
  • Liu, Linwen  ( Peking Union Medical College Hospital , Beijing , China )
  • Li, Mingli  ( Peking Union Medical College Hospital , Beijing , China )
  • Liu, Yiyang  ( Peking Union Medical College Hospital , Beijing , China )
  • Wang, Zijue  ( Peking Union Medical College Hospital , Beijing , China )
  • Si, Qianqian  ( The First Affiliated Hospital of Nanjing Medical University , Nanjing , China )
  • Yu, Qiuyu  ( Peking Union Medical College Hospital , Beijing , China )
  • Xu, Weihai  ( Peking Union Medical College Hospital , Beijing , China )
  • Author Disclosures:
    Caiyan Liu: DO NOT have relevant financial relationships | Weihai Xu: No Answer | An-Qi Cheng: DO have relevant financial relationships ; Research Funding (PI or named investigator):the National Science Fund for Distinguished Young Scholars:Active (exists now) | Yinxi Zou: DO NOT have relevant financial relationships | Linwen Liu: No Answer | MingLi LI: DO NOT have relevant financial relationships | Yiyang Liu: DO NOT have relevant financial relationships | Zijue Wang: DO NOT have relevant financial relationships | Qianqian Si: DO NOT have relevant financial relationships | Qiuyu Yu: No Answer
Meeting Info:
Session Info:

Brain Health Posters I

Wednesday, 02/05/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
Balloon-mounted versus Self-expanding stents in bail out thrombectomy: impact of the stent design in the RESISTANT registry cohort

Tomasello Alejandro, Hassan Ameer, Miller Samantha, Zapata-arriaza Elena, De Alboniga-chindurza Asier, Bergui Mauro, Molinaro Stefano, Sousa Joao Andre, Gomes Fábio, Alexandre Andrea, Pedicelli Alessandro, Salcuni Andrea, Hofmeister Jeremy, Machi Paolo, Scarcia Luca, Kalsoum Erwah, Amorim José, Meira Torcato, Ortega-gutierrez Santiago, Rodriguez Aaron, Renieri Leonardo, Capasso Francesco, Kaesmacher Johannes, Gadea Marta, Romano Daniele, Barcena Eduardo, Abdalkader Mohamad, Perry Da Camara Catarina, Yavagal Dileep, Vega Pedro, Ozdemir Atilla Ozcan, Smajda Stanislas, Khalife Jane, Mujanovic Adnan, Biraschi Francesco, Castro Pedro, Siddiqui Adnan, Navia Pedro, Ntoulias Nikolaos, Velo Mariano, Zamarro Joaquin, Zaidat Osama, Sierra-gomez Alicia, Marto Joao Pedro, Geyik Serdar, Requena Manuel, Senadim Songul, Piano Mariangela, Moreu Manuel, Lopez-frias Alfonso

Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis-Magnetic Resonance Imaging (CAPTIVA-MRI)

Wong Ka-ho, De Havenon Adam, Sulken Amy, Knebusch Clara, Reed Rachel, Faraco Carlos, Martin Renee, Amin-hanjani Sepideh, Chatterjee Arindam, Liebeskind David

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)